RECRUITING

Speech Rehabilitation Based on Mobile Applications

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates the efficacy of smartphone-based speech therapy administered at home compared with usual care. Participants will be randomized into the treatment and waitlist control groups with an allocation ratio of 1:1.

Official Title

Effect of Speech Rehabilitation Based on Mobile Application for People with Dysarthria After Stroke: a Single-Center, Investigator-Blinded, Randomized, Crossover Trial

Quick Facts

Study Start:2024-05-15

Study Completion:2024-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06592183

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Patients must be able to use a smartphone-based speech therapy application, as determined by self-reporting cognitive abilities. * Speaks English as a native language.	* Unable to use smartphone application or conduct speech assessment due to severe speech impairment. * Self-reported co-existing progressive neurological disorders that can affect dysarthria (e.g., dementia, Pick's disease, Huntington's disease, Parkinson's disease, or Parkinsonism). * Patient with severe mental disorders as self-reported (e.g., depression, schizophrenia, alcohol addiction, or drug addiction). * Illiterate patients.

Inclusion Criteria

Exclusion Criteria

* Patients must be able to use a smartphone-based speech therapy application, as determined by self-reporting cognitive abilities.
* Speaks English as a native language.

* Unable to use smartphone application or conduct speech assessment due to severe speech impairment.
* Self-reported co-existing progressive neurological disorders that can affect dysarthria (e.g., dementia, Pick's disease, Huntington's disease, Parkinson's disease, or Parkinsonism).
* Patient with severe mental disorders as self-reported (e.g., depression, schizophrenia, alcohol addiction, or drug addiction).
* Illiterate patients.

Contacts and Locations

Study Contact

Yunjung Kim

CONTACT

8506454804

ykim19@fsu.edu

Principal Investigator

Jinwoo Kim, PhD

STUDY_DIRECTOR

Haii Corp.

Study Locations (Sites)

Florida State University

Tallahassee, Florida, 32309

United States

Collaborators and Investigators

Sponsor: Florida State University

Jinwoo Kim, PhD, STUDY_DIRECTOR, Haii Corp.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-15

Study Completion Date2024-12-31

Study Record Updates

Study Start Date2024-05-15

Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

Stroke
Motor Speech Disorder